biotech · Advanced Solid Tumors · Tumor, Solid · EIKN
Eikon Therapeutics
Eikon Therapeutics patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
230 Harriet Tubman Way, Millbrae, CA 94030, US HQ
2019 Founded
404 Employees
Public company Type
EIKN · NYSE Ticker
Company details
- Status
- Public
- HQ
- 230 Harriet Tubman Way, Millbrae, CA 94030, US
- Founded
- 2019
- Employees
- 404
- Programs
- 15
- Drugs
- 13
- Patents
- 4
Eikon Therapeutics patents
4 pharmaceutical patents indexed for Eikon Therapeutics. 0 expire within 24 months.
Eikon Therapeutics has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Eikon Therapeutics have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Eikon Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.